Repository
How to publish
Resources
FAQs

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

Author:
Bandelow, Borwin; Chouinard, Guy; Bobes, JulioUniovi authority; Ahokas, Antti; Eggens, Ivan; Liu, Sherry; Eriksson, Hans
Publication date:
2010
Publisher version:
http://dx.doi.org/10.1017/S1461145709990423
Citación:
International Journal of Neuropsychopharmacology, 13(3), p. 305-320 (2010); doi:10.1017/S1461145709990423
Descripción física:
p. 305-320
URI:
http://hdl.handle.net/10651/6622
ISSN:
1461-1457
Identificador local:

20100334

DOI:
10.1017/S1461145709990423
Patrocinado por

This study (Silver: D1448C00011) was supported by AstraZeneca Pharmaceuticals.

Collections
Files in this item
Compartir
Estadísticas de uso
Estadísticas de uso
Metadata
Show full item record
© 2015 Collegium Internationale Neuro-Psychopharmacologicum
This item is protected with a Creative Commons License